Reneo Pharmaceuticals Volatility
| RPHMDelisted Stock | USD 18.20 1.40 8.33% |
Reneo Pharmaceuticals appears to be somewhat reliable, given 3 months investment horizon. Reneo Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.15, which implies the firm had a 0.15% return per unit of risk over the last 3 months. By analyzing Reneo Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.61% is justified by implied risk. Please evaluate Reneo Pharmaceuticals' Risk Adjusted Performance of 0.0865, coefficient of variation of 973.22, and Semi Deviation of 2.63 to confirm if our risk estimates are consistent with your expectations. Key indicators related to Reneo Pharmaceuticals' volatility include:
120 Days Market Risk | Chance Of Distress | 120 Days Economic Sensitivity |
Reneo Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Reneo daily returns, and it is calculated using variance and standard deviation. We also use Reneo's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Reneo Pharmaceuticals volatility.
Reneo |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Reneo Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Reneo Pharmaceuticals at lower prices. For example, an investor can purchase Reneo stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Reneo Pharmaceuticals' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against Reneo Stock
| 0.52 | TCHH | Trustcash Holdings | PairCorr |
| 0.46 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.41 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.34 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.32 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Reneo Pharmaceuticals Market Sensitivity And Downside Risk
Reneo Pharmaceuticals' beta coefficient measures the volatility of Reneo stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Reneo stock's returns against your selected market. In other words, Reneo Pharmaceuticals's beta of 0.13 provides an investor with an approximation of how much risk Reneo Pharmaceuticals stock can potentially add to one of your existing portfolios. Reneo Pharmaceuticals shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Reneo Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Reneo Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Reneo Pharmaceuticals Demand TrendCheck current 90 days Reneo Pharmaceuticals correlation with market (Dow Jones Industrial)Reneo Beta |
Reneo standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 3.96 |
It is essential to understand the difference between upside risk (as represented by Reneo Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Reneo Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in reneo stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Reneo Pharmaceuticals.
Reneo Pharmaceuticals Stock Volatility Analysis
Volatility refers to the frequency at which Reneo Pharmaceuticals delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Reneo Pharmaceuticals' price changes. Investors will then calculate the volatility of Reneo Pharmaceuticals' stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Reneo Pharmaceuticals' volatility:
Historical Volatility
This type of delisted stock volatility measures Reneo Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Reneo Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Reneo Pharmaceuticals' current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Reneo Pharmaceuticals' to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Reneo Pharmaceuticals Projected Return Density Against Market
Given the investment horizon of 90 days Reneo Pharmaceuticals has a beta of 0.1333 indicating as returns on the market go up, Reneo Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Reneo Pharmaceuticals will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Reneo Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Reneo Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Reneo delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Reneo Pharmaceuticals has an alpha of 0.3095, implying that it can generate a 0.31 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Reneo Pharmaceuticals Price Volatility?
Several factors can influence a delisted stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Reneo Pharmaceuticals Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Reneo Pharmaceuticals is 650.99. The daily returns are distributed with a variance of 15.71 and standard deviation of 3.96. The mean deviation of Reneo Pharmaceuticals is currently at 2.87. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.77
α | Alpha over Dow Jones | 0.31 | |
β | Beta against Dow Jones | 0.13 | |
σ | Overall volatility | 3.96 | |
Ir | Information ratio | 0.06 |
Reneo Pharmaceuticals Stock Return Volatility
Reneo Pharmaceuticals historical daily return volatility represents how much of Reneo Pharmaceuticals delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 3.9634% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7685% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Reneo Pharmaceuticals Volatility
Volatility is a rate at which the price of Reneo Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Reneo Pharmaceuticals may increase or decrease. In other words, similar to Reneo's beta indicator, it measures the risk of Reneo Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Reneo Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company was incorporated in 2014 and is headquartered in Irvine, California. Reneo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.
Reneo Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Reneo Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Reneo Pharmaceuticals' price varies over time.
3 ways to utilize Reneo Pharmaceuticals' volatility to invest better
Higher Reneo Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Reneo Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Reneo Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Reneo Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Reneo Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Reneo Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Reneo Pharmaceuticals Investment Opportunity
Reneo Pharmaceuticals has a volatility of 3.96 and is 5.14 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of Reneo Pharmaceuticals is lower than 35 percent of all global equities and portfolios over the last 90 days. You can use Reneo Pharmaceuticals to enhance the returns of your portfolios. The stock experiences a very speculative upward sentiment. Check odds of Reneo Pharmaceuticals to be traded at $22.75 in 90 days.Significant diversification
The correlation between Reneo Pharmaceuticals and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Reneo Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Reneo Pharmaceuticals Additional Risk Indicators
The analysis of Reneo Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Reneo Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Reneo Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0865 | |||
| Market Risk Adjusted Performance | 2.45 | |||
| Mean Deviation | 2.38 | |||
| Semi Deviation | 2.63 | |||
| Downside Deviation | 3.32 | |||
| Coefficient Of Variation | 973.22 | |||
| Standard Deviation | 3.27 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Reneo Pharmaceuticals Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Reneo Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Reneo Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Reneo Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Reneo Pharmaceuticals.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Reneo Stock
If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |